Marita Laurila
Papers
2
Total Citations
209
H-Index
2
About
Marita Laurila is a surgical oncologist and translational researcher whose work bridges the frontier of minimally invasive gynecologic oncology and precision molecular pathology. Her landmark contribution is the first randomized controlled trial comparing robotic-assisted to traditional laparoscopic surgery for endometrial cancer, a study that has garnered 189 citations and provided pivotal evidence for the safety and feasibility of robotic platforms in oncologic surgery. Beyond the operating room, Laurila has advanced the molecular characterization of prostate cancer through her 2017 study on PAXgene fixation. This work demonstrated that PAXgene-fixed, paraffin-embedded tissue preserves high-quality DNA, RNA, and protein comparable to fresh frozen samples while maintaining diagnostic histomorphology—a critical step toward integrating molecular phenotyping into routine surgical pathology. By enabling high-fidelity correlation of clinical, histologic, and genomic data, her research empowers more precise diagnostics and biomarker discovery. Laurila’s dual expertise in surgical innovation and tissue preservation positions her at the forefront of personalized cancer care, where operative technique and molecular insight converge to improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2